Zuellig Pharma Corporation, Amgen Philippines Inc, they aim to help improve awareness of cardiovascular disease (CVD)



 

Cardiovascular disease, any of the diseases, whether congenital or acquired, of the heart and blood vessels. Among the most important are atherosclerosis, rheumatic heart disease, and vascular inflammation. Cardiovascular diseases are a major cause of health problems and death.

 

Life depends on the functioning of the heart, to some degree, as medical science advances, more people are saved from other illnesses only to die from one of the unsolved and uncontrolled disorders of the cardiovascular system. Some forms of cardiovascular diseases are becoming less frequent causes of death, and continued research and preventive measures may provide even greater benefits.

 

Zuellig Pharma Corporation recently launches One Family, One Heart, One Goal Bloggers' Event earlier at the Crowne Plaza to spread Cardiovascular disease awareness. Dr. Lourdes Ella Santos, Adult Cardiologist and Clinical Lipidologist shared about cardiovascular disease and focused on Dyslipidemia (abnormal amount of cholesterol) in the blood.

 

Key facts

• CVDs are the number 1 cause of death globally: more people die annually from CVDs than from any other cause.
• An estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. Of these deaths, 85% are due to heart attack and stroke.
• Over three quarters of CVD deaths take place in low- and middle-income countries.
• Out of the 17 million premature deaths (under the age of 70) due to noncommunicable diseases in 2015, 82% are in low- and middle-income countries, and 37% are caused by CVDs.
• Most cardiovascular diseases can be prevented by addressing behavioural risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol using population-wide strategies.
• People with cardiovascular disease or who are at high cardiovascular risk (due to the presence of one or more risk factors such as hypertension, diabetes, hyperlipidaemia or already established disease) need early detection and management using counselling and medicines, as appropriate.

 

There are two types of cholesterol: LDL and HDL. Low-density lipoproteins (LDL) are sometimes called “bad” cholesterol. High levels of LDL cholesterol can build up in your arteries, causing heart disease. High-density lipoproteins (HDL) are referred to as “good” cholesterol.

 

In order to find the key to prevent and predict devastating health events like a heart attack, we need to find the right connection. Zuellig Pharma Corporation and Amgen Phililippines Inc. united to help improve awareness of cardiovascular diseases (CVD), to educate people on how to manage and prevent the disease.

 

The standard treatment for lowering LDL-C are statins, but there are cases when statins are not enough. Having access to new and innovative treatments in the management of dyslipidemia can make a difference for patients who are not able to achieve their lipid goals with statin alone.

 

With the patient at the heart of what we do, Amgen Philippines Inc. and Zuellig Pharma Corporation are committed to improving the lives of patients struggling with dyslipidemia by helping them and their families to take the necessary action to prevent and manage their health risks.